Market News AIOpen the app

Lakefront Biotherapeutics is starting a new program to buy back up to €50 million of its shares.

PayoutRead the original at ayondo.com
Good for LKFT

The authorization allows up to €50 million in share purchases, and management says it reflects its view of the company's current value. Repurchased shares may go to employee awards, but the company also says pipeline investment will continue.

LKFT · Lakefront Biotherapeutics NV

AI read · Good for LKFT

The AI's read

The plan directs company money toward its own shares, and management says it reflects its view of their current value. Repurchased shares may be kept for employee awards instead of removed permanently. The company also says it will keep investing in its clinical-stage pipeline.

Get alerts for LKFT

Follow Lakefront Biotherapeutics NV (LKFT) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for LKFT
Free on the App Store and Google Play, or on the web.